CAN
GMAB icon

Claraphi Advisory Network’s Genmab GMAB Stock Holding History

Claraphi Advisory Network’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-6,652
Closed -$270K – 320
2020
Q4 		$270K Sell
6,652
-212
-3% -$7.92K 0.07% 224
2020
Q3 		$251K Buy
+6,864
New +$248K 0.09% 193

Other funds holding GMAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Claraphi Advisory Network's GMAB Position: Q1 2021 in Review

Claraphi Advisory Network sold out of Genmab (GMAB) in Q1 2021, closing a stake of 6,652 shares — an estimated $270K sold.

Claraphi Advisory Network first reported a position in GMAB in Q3 2020 and held it in 2 quarters. The position peaked at $270K in Q4 2020. 209 funds tracked by Wall St. Rank hold GMAB as of Q1 2021.

  • Claraphi Advisory Network reported no remaining Genmab position as of Q1 2021 after selling out during the quarter.
  • Claraphi Advisory Network sold 6,652 Genmab shares in Q1 2021, an estimated $270K.
  • Claraphi Advisory Network first reported a position in Genmab in Q3 2020 and held it in 2 quarters.
  • Claraphi Advisory Network's Genmab position peaked at $270K in Q4 2020.
  • 209 funds tracked by Wall St. Rank held Genmab as of Q1 2021.

Based on Claraphi Advisory Network's 13F filing for Q1 2021, filed 30 Apr 2021.